Elcin Zan, MD
Nuclear Imaging & Therapy · New York, NYNPI 1639441215
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.6%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Novartis at 26.4% of the total. 2025 is the largest year on record at $14,567, 2.4 times the $6,076 reported in 2019.
Across 54 payments — averaging $560.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$8K
- Siemens Medical Solutions USA, Inc.$8K
- Advanced Accelerator Applications$6K
- Genentech, Inc.$4K
- Astrazeneca UK Limited$2K
- Curium US LLC$2K
- plus $567 from 5 others
Across 1 payment — averaging $30,355 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$30K
What the payments were for
- Consulting fees$12,60542%
- Speaking & faculty fees$5,62019%
- Travel & lodging$10,29434%
- Food & beverage$1,7536%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 6 | $7,989 |
| Siemens Medical Solutions USA, Inc. | 23 | $7,968 |
| Advanced Accelerator Applications | 5 | $5,956 |
| Genentech, Inc. | 4 | $4,197 |
| Astrazeneca UK Limited | 1 | $1,860 |
| Curium US LLC | 7 | $1,737 |
| Telix Pharmaceuticals | 2 | $177 |
| AstraZeneca | 2 | $154 |
| GE HealthCare | 2 | $126 |
| Canon Healthcare USA, Inc. | 1 | $86 |
| Blue Earth Diagnostics | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lutathera$5,956
- Symbia Pro.specta Q3$1,416
- Biograph Trinion EP CT64$562
- ILLUCCIX$139
- LYNPARZA$131
How this compares
Too few nuclear imaging & therapy providers in New Yorkto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear imaging & therapy in New York
- Lisa BodeiNew York$1K
- Preeti KakkarNew York$161
- Somali GavaneNew York$56
- Wolfgang WeberNew York$42
- Lawrence FleshAlbany$8K
- Jean-Luc UrbainBuffalo$4K
- Changping JiaBrooklyn$1K
- Eugene FineBronx$596
- Hani Abdel NabiBuffalo$232
- Jonathan KhodadadianLindenhurst$141
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.